Skip to content
Disclosery

Medicxi Ventures Management (Jersey) Ltd

Follow

13F filer, CIK 1715579, ST. HELIER, Jersey

Medicxi Ventures Management (Jersey) Ltd reported $177,424,615 across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-04.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-332000

Period
2026-06-30
Reported value
$177M
Holdings
3
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CNTAexited-19,963,157-$793M
NAMSreduced-465,543-$15.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001193125-26-332000, largest first. % of portfolio is the value over $177,424,615, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,464,572 shares; 2024Q4: 7,464,572 shares; 2025Q1: 7,464,572 shares; 2025Q2: 7,464,572 shares; 2025Q3: 7,464,572 shares; 2025Q4: 7,464,572 shares; 2026Q1: 7,464,572 shares; 2026Q2: 7,464,572 shares 7,464,572$81M45.65%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,869,565 shares; 2024Q4: 2,869,565 shares; 2025Q1: 2,869,565 shares; 2025Q2: 2,869,565 shares; 2025Q3: 2,869,565 shares; 2025Q4: 2,869,565 shares; 2026Q1: 2,674,182 shares; 2026Q2: 2,208,639 shares 2,208,639$74.9M42.19%-465,543Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,039,892 shares; 2024Q4: 3,039,892 shares; 2025Q1: 3,039,892 shares; 2025Q2: 3,039,892 shares; 2025Q3: 3,039,892 shares; 2025Q4: 3,039,892 shares; 2026Q1: 3,039,892 shares; 2026Q2: 3,039,892 shares 3,039,892$21.6M12.16%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CNTACENTESSA PHARMACEUTICALS PLC19,963,157$793Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-332000 base2026-08-04acceptance time not in the bulk data set